Combined Deep Brain Stimulation for Parkinson's Disease
Trial
Phase 1
Withdrawn
Nov. 14, 2019
Effects of Cholinergic Augmentation on Measures of Balance and Gait
Trial
Phase 2
Completed
Nov. 13, 2019
Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease
Trial
Phase 3
Terminated
Nov. 12, 2019
Priming Through Timing. Using Opposing Strategies to Enhance Motor Learning for Individuals With Parkinson's Disease
Trial
N/A
Completed
Nov. 12, 2019
A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
Trial
Phase 2
Completed
Nov. 7, 2019
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
Trial
Phase 3
Completed
Nov. 7, 2019
Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study
Trial
Phase 3
Completed
Nov. 6, 2019
Pilot Trial of Transnasal Nicotine in Parkinson Disease
Trial
Phase 2
Completed
Nov. 5, 2019
A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
Trial
Phase 2
Completed
Nov. 5, 2019
Diagnostic Tools for Parkinson's Disease
Trial
N/A
Completed
Nov. 3, 2019
7T MRS in Parkinson's Disease
Trial
N/A
Completed
Oct. 31, 2019
Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease
Trial
Phase 1
Completed
Oct. 31, 2019
Functional Connectivity Parkinson Disease
Trial
N/A
Completed
Oct. 31, 2019
Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes
Trial
N/A
Completed
Oct. 31, 2019
Video Based Mindfulness Based Stress Reduction
Trial
N/A
Completed
Oct. 30, 2019
Learning Effective New Strategies for Worry in Parkinson's Disease
Trial
N/A
Unknown
Oct. 30, 2019
Helicobacter Pylori Eradication Study in Parkinson's Disease
Trial
N/A
Completed
Oct. 29, 2019
Transcranial Direct Current Stimulation (tDCS) and Parkinson's Disease
Trial
N/A
Completed
Oct. 29, 2019
Trial of Probiotics for Constipation in Parkinson's Disease
Trial
N/A
Completed
Oct. 29, 2019
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Trial
Phase 3
Completed
Oct. 28, 2019